RSS

prostate cancer

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

According to new research from the US, a side-effect of a common prostate cancer drug can, in some men with advanced disease who have a specific genetic variant, actually fuel cancer cells. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

Data has been presented by AstraZeneca and Merck demonstrating clinical improvement in median radiologic progression-free survival (rPFS) with Lynparza (olaparib) in combination with abiraterone compared to abiraterone monotherapy, a standard of care more

News

The US Food and Drug Administration has approved a new treatment (Elreada) for patients with prostate cancer that is non-metastatic but continues to grow despite being treated with hormone therapy. more

News

The Netherlands Cancer Institute (NKI) is the recipient of funds from the Dutch Cancer Society (KWF Kankerbestrijding) to apply molecular imaging technology to guide prostate cancer surgery, it has been announced. more

Technology

A study, from an international team of researchers, may offer hope to patients with prostate cancer as it shows that a combination therapy could potentially reduce the recurrence rate of the disease. more

News

Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have collaborated to set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm’s development facility in Solna, Sweden. more

News

Bayer and Orion today announced the expansion of the global clinical development programme for an investigational androgen receptor (AR) antagonist in the area of prostate cancer more

News

Due to a price drop, the National Institute for Health and Care Excellence (NICE) has agreed that Janssen’s prostate cancer drug, abiraterone is now affordable, going back on its previous decision more

News

Docetaxel immediately given to patients diagnosed with advanced prostate cancer to help extend their lives more

News

The US Food and Drug Administration (FDA) has approved Nanobiotix’s Investigational New Drug (IND) application for the clinical study of NBTXR3 to treat prostate cancer more

News

A new assay is under development which would allow researchers to test the effectiveness of certain cancer drugs. more

News

Thousands more cancer patients in England will be offered vital treatments in a £160 million boost to the Cancer Drugs Fund. more

The licensed technology pioneers the use of lanthanide complexes for the non-invasive, rapid and accurate measurement of citrate levels in seminal fluid. more